Deutsche Bank’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-101,113
| Closed | -$62.7K | – | 3577 |
|
|
2025
Q1 | $62.7K | Hold |
101,113
| – | – | ﹤0.01% | 3302 |
|
|
2024
Q4 | $169K | Buy |
101,113
+84,830
| +521% | +$142K | ﹤0.01% | 3103 |
|
|
2024
Q3 | $29.6K | Buy |
16,283
+5,849
| +56% | +$10.6K | ﹤0.01% | 3381 |
|
|
2024
Q2 | $62.9K | Sell |
10,434
-1,054
| -9% | -$6.36K | ﹤0.01% | 3233 |
|
|
2024
Q1 | $128K | Buy |
11,488
+366
| +3% | +$4.08K | ﹤0.01% | 3009 |
|
|
2023
Q4 | $166K | Buy |
11,122
+333
| +3% | +$4.96K | ﹤0.01% | 2929 |
|
|
2023
Q3 | $51.8K | Sell |
10,789
-182,686
| -94% | -$877K | ﹤0.01% | 3374 |
|
|
2023
Q2 | $1.45M | Sell |
193,475
-153,314
| -44% | -$1.15M | ﹤0.01% | 1778 |
|
|
2023
Q1 | $1.57M | Buy |
346,789
+4,434
| +1% | +$20K | ﹤0.01% | 1823 |
|
|
2022
Q4 | $3.86M | Buy |
342,355
+142
| +0% | +$1.6K | ﹤0.01% | 1323 |
|
|
2022
Q3 | $3.28M | Buy |
342,213
+394
| +0.1% | +$3.77K | ﹤0.01% | 1387 |
|
|
2022
Q2 | $2.77M | Sell |
341,819
-1,844
| -0.5% | -$14.9K | ﹤0.01% | 1585 |
|
|
2022
Q1 | $5.81M | Buy |
343,663
+332,243
| +2,909% | +$5.61M | ﹤0.01% | 1334 |
|
|
2021
Q4 | $245K | Sell |
11,420
-4,203
| -27% | -$90.2K | ﹤0.01% | 3250 |
|
|
2021
Q3 | $1.15M | Buy |
15,623
+4,360
| +39% | +$322K | ﹤0.01% | 2511 |
|
|
2021
Q2 | $616K | Sell |
11,263
-345
| -3% | -$18.9K | ﹤0.01% | 3067 |
|
|
2021
Q1 | $855K | Buy |
11,608
+4,476
| +63% | +$330K | ﹤0.01% | 2747 |
|
|
2020
Q4 | $615K | Buy |
7,132
+2,024
| +40% | +$175K | ﹤0.01% | 2743 |
|
|
2020
Q3 | $193K | Buy |
+5,108
| New | +$193K | ﹤0.01% | 3197 |
|